Pharma feed

Zoetis Inc
Zoetis· 21 Feb 2018

Cowen and Company 38th Annual Health Care Conference

Zoetis Inc. will participate in the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018, in Boston, Mass. Clint Lewis, Executive Vice President and President, International Operations, will represent the company and respond to questions from analysts.

  • Zoetis Inc
  • Cowen Group
  • Events
  • Company Websites
N
Novartis AG
Firstwordpharma· 21 Feb 2018

Greece: 2 ex-ministers sue witnesses in pharma bribe case

Former Greek deputy prime minister Evangelos Venizelos and former health Adonis Georgiadis have filed lawsuits against witnesses who potentially implicated them in a bribery scandal involving Novartis, as reported ABC News Wednesday. In the case, a number of Greek officials have been accused of accepting kickbacks from the drugmaker to boost sales and prices in the country.

  • Novartis AG
  • Regulatory & Legal
  • Negative News
  • News Articles
  • News and Other Websites
  • Pfizer Inc.
  • Events
  • Social Updates
  • Twitter
N
AstraZeneca PLC
Pharmafile· 21 Feb 2018

AZ licenses kidney drug from Ionis for $330m

Published on 21/02/18 at 10:02am AstraZeneca continues to build on its relationship with San Diego-based Ionis Pharmaceuticals, this time by agreeing a licensing deal for a drug to be developed for the treatment of kidney disease.

  • AstraZeneca PLC
  • Ionis Pharmaceuticals
  • Regulatory & Legal
  • News Articles
  • News and Other Websites
N
Pfizer Inc.
Fierce Biotech· 21 Feb 2018

Pfizer’s John Davis splashes into biotech as Magenta CMO

Magenta Therapeutics has appointed a new chief medical officer: John Davis, M.D., who was previously a senior vice president and head of early clinical development at Pfizer. The startup, which raised $50 million in series B funding last May, is working on targeted therapeutics to make stem cell transplants safer and more effective.

  • Pfizer Inc.
  • Funding Activity
  • News Articles
  • News and Other Websites
  • Exelixis Inc
  • Events
  • Social Updates
  • Twitter
Eli Lilly and Co
Lilly· 21 Feb 2018

Lilly to Participate in Barclays Global Healthcare Conference (NYSE

INDIANAPOLIS , Feb. 21, 2018 /PRNewswire/ -- Eli Lilly and Company ( NYSE : LLY) will participate in the Barclays Global Healthcare Conference on Wednesday, March 14, 2018 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a fireside chat at 8:30 a.m., Eastern Time .

  • Global Healthcare
  • Eli Lilly and Co
  • Events
  • Company Websites
N
Teva Pharmaceutical Industries Ltd
PRWeb· 21 Feb 2018

Teva Announces New Brand Positioning and Visual Identity in North America

FRAZER, Pa. (PRWEB) February 21, 2018 • The new brand will roll out globally throughout 2018, focusing on the most impactful brand touch points Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the rollout in North America of its new brand positioning and visual identity, including a new logo, as part of a global brand rollout.

  • Teva Pharmaceutical Industries Ltd
  • New Offerings
  • Press Releases
  • Wired News
N
Novartis AG
Fiercepharma· 21 Feb 2018

Officials in Greek Novartis probe fire back at protected witnesses: report

Just as Greek lawmakers kick off discussions about the country's Novartis bribery probe and the alleged role of former officials, some of those politicians have filed criminal lawsuits against the protected, unidentified witnesses who have named them, according to the Associated Press.

  • Novartis AG
  • Regulatory & Legal
  • Negative News
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
Globalcosmeticsnews· 21 Feb 2018

Johnson & Johnson Innovation opens public-private office in Australia

Johnson & Johnson Innovation has cut the ribbon on its Johnson & Johnson Innovation Partnering Office @ Monash (JJIPO@Monash) in collaboration with the Victorian State Government and Monash University. The initiative aims to accelerate healthcare innovation and commercialization in Victoria, Australia, and beyond.

  • Johnson & Johnson
  • Monash University
  • Partnerships & Alliances
  • Business Expansion
  • News Articles
  • News and Other Websites
Takeda Pharmaceutical Co Ltd
Takeda· 21 Feb 2018

Takeda's Sustainable Value Report 2017 Receives Excellence Award in 21st Environmental Communication Awards

The Environmental Communication Awards recognize reports and other communications activity that contribute significantly to the advancement of environmental management and communication in business and improve the quality of environmental information disclosure. Takeda was recognized for its established track record in sustainability and unwavering commitment to improving access to healthcare, guided by long-term international targets such as the United Nations' Sustainable Development Goals (SDGs).

  • Takeda Pharmaceutical Co Ltd
  • Awards & Recognitions
  • Press Releases
  • Company Websites
N
Merck & Co., Inc.
Investing· 21 Feb 2018

Merck to buy Viralytics for $394 million to boost immuno-oncology By Reuters

Merck to buy Viralytics for $394 million to boost immuno-oncology Stock Markets 2 hours ago (Feb 21, 2018 09:31) © Reuters. Merck to buy Viralytics for $394 million to boost immuno-oncology (Reuters) - U.S. drugmaker Merck (NYSE: ) & Co, already one of the leaders in the hot area of cancer immunotherapy, said on Wednesday it had agreed to buy Viralytics for 502 million Australian dollars ($394 million) to expand its drug pipeline.

  • Merck & Co., Inc.
  • M&A Activities
  • News Articles
  • News and Other Websites
Johnson & Johnson
Jnj· 21 Feb 2018

Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference

New Brunswick, NJ (Feb. 20, 2018) -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 38th Annual Healthcare Conference on Tuesday, Mar. 13, at The Boston Marriott Copley Place, Boston. Ashley McEvoy, Company Group Chairman, Consumer Medical Devices will represent the Company in a session scheduled at 10:00 a.m.

  • Cowen Group
  • Johnson & Johnson
  • Events
  • Company Websites
N
Sanofi
Factsweek· 21 Feb 2018

Vitamin B12 China Market Demand and Competitive Analysis by Leading Manufacturers (Sanofi, Hebei Yufeng Group, Hebei Huarong Pharmaceutical) – Facts Week

HTF MI presents an in-depth assessment of current Vitamin B12 key market drivers, market size and trends and China Vitamin B12 opportunities, challenges, and restraints as well as key market segments, technological updates, impact of any regulatory policies as well as key market segments.

  • Sanofi
  • Competitive Landscape
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Genetic Engineering & Biotechnology News· 21 Feb 2018

Merck to Acquire Oncolytic Immunotherapy Developer Viralytics for $394M

Merck & Co. has agreed to acquire Sydney-based Viralytics for approximately A$502 ($394 million), the companies said today, in a deal that expands the buyer’s immuno-oncology pipeline with a mid-stage oncolytic immunotherapy that has already shown positive clinical data in combination trials.

  • Merck & Co., Inc.
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Amgen, Inc.
Fiercepharma· 21 Feb 2018

Amgen sued FDA for a 6-month reprieve from Sensipar generics—and lost

Amgen has more than a billion dollars in annual sales riding on its ability to protect calcium reducer Sensipar from generic competition, but now its defenses have suffered a legal defeat. On Tuesday, a U.S. District Judge nixed Amgen's attempt to squeeze six extra months of exclusivity out of the FDA.

  • Amgen, Inc.
  • Regulatory & Legal
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Investmenteurope· 21 Feb 2018

Merck Finck appoints Martin Deckert as CEO

The private bank Merck Finck has appointed Martin Deckert as a new member of its executive board. Subject to the approval of the Financial Regulator Bafin, Deckert take over his new role on 1 May 2018.

  • Merck & Co., Inc.
  • Management Changes
  • News Articles
  • News and Other Websites
N
Pfizer Inc.
Firstwordpharma· 21 Feb 2018

Reckitt Benckiser Group's bid to buy Pfizer unit a step in the right direction, says JP Morgan

JP Morgan analysts indicated that Reckitt Benckiser's bid to purchase Pfizer's consumer healthcare business is a positive step, Proactive Investors reported Tuesday. "We see a potential acquisition as a strategic step toward building a global powerhouse in consumer health, which may not require an equity raise as feared by the market," the analysts stated.

  • Pfizer Inc.
  • JPMorgan Chase & Co.
  • reckitt benckiser
  • M&A Activities
  • News Articles
  • News and Other Websites
Celgene Corp
Celgene· 21 Feb 2018

Celgene Receives Antitrust Clearance for Juno Acquisition (NASDAQ

SUMMIT, N.J. --(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced tender offer by Celgene's wholly owned subsidiary, Blue Magpie Corporation , for all issued and outstanding shares of common stock of Juno Therapeutics, Inc.

  • Celgene Corp
  • Regulatory & Legal
  • Company Websites
Zoetis Inc
Zoetis· 21 Feb 2018

Zoetis to Participate in the Cowen and Company 38th Annual Health Care Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018, in Boston, Mass. Clint Lewis, Executive Vice President and President, International Operations, will represent the company and respond to questions from analysts.

  • Zoetis Inc
  • Cowen Group
  • Events
  • Company Websites
N
Johnson & Johnson
Fierce Biotech· 21 Feb 2018

Johnson & Johnson beefs up its surgery robotics tech with acquisition of French company

Johnson & Johnson is beefing up its presence in the robotic surgery arena with the acquisition by its unit Apsis of French robot-assisted surgery company Orthotaxy for an undisclosed price. The company said the deal for Orthotaxy is part of its strategy to create a new robot-assisted platform for orthopedic surgeries beyond its current early stage technology focused on total and partial knee replacements.

  • Johnson & Johnson
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Biopharmadive· 21 Feb 2018

Gilead wins reprieve in Merck's $2.5B patent lawsuit

Dive Brief: Gilead Sciences Inc. doesn't have to hand over billions of dollars to rival drugmaker Merck & Co. for patent violations — at least not yet, anyway — after a federal judge reversed an earlier decision concerning a lawsuit between the drugmakers.

  • Merck & Co., Inc.
  • Regulatory & Legal
  • News Articles
  • News and Other Websites
N
E I Du Pont De Nemours And Co
Openpr· 21 Feb 2018

Global Canola Seed Market 2018-Monsanto, Dupont, Syngenta, Bayer, Dow, Calyxt

Global Canola Seed Market Global Canola Seed Market Apex Market Reports, recently published a detailed market research study focused on the "Global Canola Seed Market" across the global, regional and country level. The report provides 360° analysis of "Global Canola Seed Market" from view of manufacturers, regions, product types and end industries.

  • E I Du Pont De Nemours And Co
  • Syngenta
  • Bayer AG
  • Awards & Recognitions
  • News Articles
  • News and Other Websites
N
E I Du Pont De Nemours And Co
Openpr· 21 Feb 2018

Global Corn Hybrids Market 2018- Dupont, Syngenta, Monsanto, Bayer, KWS, Dow

Global Corn Hybrids Market Global Corn Hybrids Market Apex Market Reports, recently published a detailed market research study focused on the "Global Corn Hybrids Market" across the global, regional and country level. The report provides 360° analysis of "Global Corn Hybrids Market" from view of manufacturers, regions, product types and end industries.

  • E I Du Pont De Nemours And Co
  • Bayer AG
  • Syngenta
  • Monsanto Company
  • Awards & Recognitions
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
Capitalfm· 21 Feb 2018

MOH partners with Johnson & Johnson to aid cancer control strategy Capital News

, KISUMU, Kenya, Feb 21 – The Ministry of Health has stepped up ongoing efforts to raise awareness on the National Cancer Control Strategy 2017-2022. Through a series of regional workshops targeting county health management teams, the Ministry of Health is undertaking consultative training initiatives in various parts of the country, to sensitise county stakeholders to spur activity aimed at implementing the interventions captured in the National Cancer Control Strategy 2017-2022.

  • Johnson & Johnson
  • Partnerships & Alliances
  • News Articles
  • News and Other Websites
1 2 3 4 5